Table 4: Medical treatment of NTM keratitis.

Mode of deliveryNumber of eyes

Topical108 (53.2%)
Topical and systemic85 (41.9%)
Systemic5 (2.5%)
Topical, systemic, and periocular2 (1%)
Topical and intraocular1 (0.5%)
Topical and periocular1 (0.5%)
Systemic and periocular1 (0.5%)

Antibiotic (ATB) regimenNumber of eyes

Amikacin alone56 (29.2%)
Amikacin + macrolide27 (14.1%)
Amikacin + fluoroquinolone24 (12.5%)
Amikacin + fluoroquinolone + macrolide18 (9.4%)
Fluoroquinolone + macrolide16 (8.3%)
Other*14 (7.3%)
Fluoroquinolone alone13 (6.8%)
Amikacin + 1 or more ATB*11 (5.7%)
Macrolide + 1 or more ATB*7 (3.6%)
Macrolide alone5 (2.6%)
Fluoroquinolone + 1 more ATB*1 (0.5%)

*Antibiotic not including amikacin/fluoroquinolone/macrolide.